| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.81B | 10.97B | 9.95B | 8.15B | 7.54B |
| Gross Profit | 2.14B | 2.33B | 2.12B | 1.17B | 1.04B |
| EBITDA | 1.68B | 1.87B | 1.71B | 833.18M | 574.07M |
| Net Income | 1.09B | 1.31B | 1.03B | 393.78M | 276.30M |
Balance Sheet | |||||
| Total Assets | 11.79B | 11.02B | 10.60B | 9.99B | 9.10B |
| Cash, Cash Equivalents and Short-Term Investments | 1.25B | 704.57M | 726.28M | 1.24B | 835.97M |
| Total Debt | 1.74B | 809.26M | 2.14B | 3.12B | 2.79B |
| Total Liabilities | 4.53B | 4.48B | 5.17B | 5.53B | 5.18B |
| Stockholders Equity | 7.19B | 6.54B | 5.43B | 4.45B | 3.92B |
Cash Flow | |||||
| Free Cash Flow | 564.12M | 667.78M | 558.58M | 208.12M | -1.02B |
| Operating Cash Flow | 1.12B | 1.25B | 996.80M | 805.42M | 382.13M |
| Investing Cash Flow | -553.08M | -515.28M | -306.31M | -681.67M | -1.34B |
| Financing Cash Flow | -163.12M | -733.82M | -1.13B | 89.88M | 1.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$4.99B | 4.10 | 15.47% | 8.39% | 7.65% | -16.88% | |
73 Outperform | HK$159.52B | 19.54 | 24.34% | 4.35% | 16.74% | 24.19% | |
65 Neutral | HK$43.03B | 12.26 | 12.26% | 1.39% | 11.26% | 15.82% | |
62 Neutral | HK$11.92B | 20.26 | 4.89% | 1.02% | 7.11% | 65.26% | |
62 Neutral | HK$10.31B | 28.99 | 8.17% | ― | 11.61% | -12.63% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$13.73B | 24.10 | 8.45% | 1.37% | 24.97% | 0.39% |